STOCK TITAN

MetLife (MET) Stock News

MET NYSE

Welcome to our dedicated page for MetLife news (Ticker: MET), a resource for investors and traders seeking the latest updates and insights on MetLife stock.

MetLife, Inc. provides insurance, annuities, employee benefits and asset management through subsidiaries and affiliates serving individual and institutional customers. Founded in 1868, the company operates in more than 40 markets and reports activity across the United States, Asia, Latin America, Europe and the Middle East.

Company updates commonly cover quarterly results, net investment income, variable investment income, financial supplements, capital deployment and dividends. News also includes developments at MetLife Investment Management, including private fixed income origination and PineBridge Investments, as well as employee-benefits research and shareholder communications such as responses to unsolicited mini-tender offers.

Rhea-AI Summary

MetLife (NYSE: MET) named Jordan Canter as head of Federal Government Affairs and Regulatory Policy, effective April 20, 2026. Based in Washington, D.C., Canter will oversee federal government affairs and global regulatory policy and report to Susan Greenwell, senior vice president and head of Global Government Affairs.

Canter joins from Allstate and previously worked at The Hartford and Bank Policy Institute; she holds a bachelor’s degree from Franklin & Marshall College.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
none
-
Rhea-AI Summary

MetLife (NYSE: MET) released its 24th Annual U.S. Employee Benefit Trends Study on March 16, 2026, finding widespread AI adoption and rising employee concerns. Key findings: 80% of employers use AI in everyday tasks; 83% say AI improves efficiency; 61% of employees worry about AI risks.

The study highlights gaps in how success is defined, the value of human-centered skills, and calls for benefits and skill development to support workforce resilience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.75%
Tags
AI
-
Rhea-AI Summary

MetLife (NYSE: MET) warns shareholders to reject an unsolicited mini-tender by Potemkin Limited to buy up to 10,000 shares (~0.002% of outstanding) at $51.60 per share, about 27.09% below the $70.77 closing price on March 9, 2026.

MetLife is not associated with Potemkin, recommends shareholders take no action, and notes the offer expires April 7, 2026, 5:00 p.m. ET. The company cites SEC guidance cautioning investors about mini-tender risks and urges shareholders to consult brokers or advisors and review withdrawal rights.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
Rhea-AI Summary

MetLife (NYSE: MET) confirmed the previously declared Q1 2026 dividend of $0.31501229 per share on its floating-rate non-cumulative preferred stock, Series A (NYSE: MET PRA).

The dividend is payable March 16, 2026 to holders of record as of Feb. 27, 2026; the NYSE will set the ex-dividend date following this confirmation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.52%
Tags
dividends
-
Rhea-AI Summary

MetLife (NYSE: MET) appointed Dan Glaser and Michelle Seitz to its Board of Directors, effective February 24, 2026. Both bring deep industry experience: Glaser with 40+ years in commercial insurance and brokerage, and Seitz with 30+ years in investment management and senior CEO roles.

The appointments are intended to strengthen board expertise supporting MetLife’s strategy and shareholder oversight.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.04%
Tags
management
-
Rhea-AI Summary

MetLife (NYSE: MET) announced that Ramy Tadros, regional president of U.S. Business and head of MetLife Holdings, will speak at the Raymond James 47th Annual Institutional Investors Conference on March 4, 2026 at 10:25 a.m. ET.

A live webcast begins at that time and a replay will be available through March 11, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
none
Rhea-AI Summary

MetLife (NYSE: MET) released findings from its 2026 Employee Benefit Trends Study showing 77% of employees intend to stay with their employer, but 56% stay out of necessity. Financial confidence is at its lowest since 2012 and 31% cite a risky job market as a reason to stay.

The study links connection at work to better outcomes: connected employees are 3x more likely to be healthy, 2x more likely to be engaged, and 3x more likely to stay by choice.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
none
-
Rhea-AI Summary

MetLife (NYSE:MET) research finds rising retirement insecurity: 58% of pre-retirees worry about running out of money and 51% of retirees with DC plan balances share that fear, up sharply from about 30% a decade ago. Pre-retirees now expect savings to last 15 years vs 19 years four years earlier.

The study highlights faster depletion for lump sum recipients, growing demand for guidance (pre-retiree guidance rising to 95%), and stronger interest in guaranteed lifetime income such as annuities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
none
-
Rhea-AI Summary

MetLife (NYSE: MET) announced that CFO John McCallion provided a fourth quarter and full year 2025 financial update video on February 4, 2026. The video is available on the company's newsroom and investor website. Contact details for media and investor inquiries were included.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.45%
Tags
Rhea-AI Summary

MetLife (NYSE: MET) reported full year and 4Q 2025 results. For the year, net income was $3.2 billion ($4.71 per share) and adjusted EPS rose ~10% to $8.89. Premiums, fees and other revenues were $57.6 billion (+10%). Adjusted ROE was 16% (midpoint of target); BVPS rose 14% to $39.02. MetLife returned nearly $4.4 billion to shareholders and held $3.6 billion in holding company cash. In 4Q25, net income was $778 million ($1.17), adjusted EPS grew to $2.58 excluding notable items, and PFOs were $18.7 billion (+29%).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.45%
Tags

FAQ

What is the current stock price of MetLife (MET)?

The current stock price of MetLife (MET) is $96.21 as of August 25, 2026.

What is the market cap of MetLife (MET)?

The market cap of MetLife (MET) is approximately 61.1B.